Dermatology Excimer Laser Market Report: Market Size & Forecast 2026

Dermatology excimer lasers are 308 nm UVB-emitting devices used by clinicians to deliver narrow-band phototherapy directly to affected lesions, sparing surrounding healthy skin. The market was valued at approximately USD 0.69 billion in 2025 and is forecast to grow at a compound annual rate of around 10.3%, reaching roughly USD 1.88 billion by 2035. North America currently leads adoption due to established reimbursement and a large dermatology base, while Asia-Pacific is the fastest-growing region.

• •Global value of about USD 0.69 billion in 2025, projected to reach USD 1.88 billion by 2035.
• •Core indications include psoriasis, vitiligo, atopic dermatitis, and leukoderma.
• •North America holds the leading share, with Asia-Pacific growing the quickest.

Rising global incidence of autoimmune and inflammatory skin conditions is creating steady clinical demand for targeted phototherapy. Greater preference for non-systemic, outpatient treatments and improving reimbursement for excimer laser procedures in mature markets are accelerating adoption. Technological advances such as hand-held and trolley-mounted form factors are expanding the range of clinical settings where these devices can be deployed.

• •Increasing prevalence of psoriasis and vitiligo worldwide.
• •Patient and clinician preference for non-systemic, localized therapy.
• •Broader reimbursement coverage and growth of private dermatology clinics.

By product, the market is split into table-top, hand-held, and trolley-mounted excimer laser systems, with table-top devices representing the largest share and hand-held units growing quickly. By application, psoriasis remains the leading segment, followed by vitiligo, atopic dermatitis, and other dermatological uses. Regionally, North America leads revenue, Europe holds a mature installed base, and Asia-Pacific is expected to post the highest growth as healthcare access broadens.

• •Table-top systems dominate product sales; hand-held models are the fastest-growing product type.
• •Psoriasis is the largest clinical application, with vitiligo as the second key segment.
• •Asia-Pacific is forecast as the fastest-growing regional market through 2035.

What are the recent trends and outlook?

Manufacturers are concentrating on miniaturization, lower acquisition and service costs, and integration with digital dermatology platforms to support telemedicine and remote monitoring. Combination protocols pairing excimer lasers with biologics or topical agents are emerging as a clinical differentiator. Over the forecast period, the market is expected to benefit from rising healthcare spending in emerging economies, broader insurance coverage, and growing awareness of advanced phototherapy options.

• •Development of compact, clinic-friendly hand-held excimer systems.
• •Growing interest in excimer laser combination protocols with topical or biologic therapies.
• •Rising dermatology investment in China, India, and the Middle East supporting long-term expansion.